Knockout mice challenge our concepts of glucose homeostasis and the pathogenesis of diabetes mellitus

Journal of Pediatric Endocrinology and Metabolism

Volumn 13, Issue SUPPL. 6, 2000, Pages 1377-1384

  Kahn, C R ^a   Bruning J C ^a   Michael, M D ^a   Kulkarni, R N ^a  

^a JOSLIN DIABETES CENTER   (United States)

Author keywords

Diabetes mellitus; Glucose homeostasis; Insulin action; Insulin receptor substrates; Insulin receptors; Insulin resistance; Phosphatidylinositol 3 kinase

Indexed keywords

CONFERENCE PAPER; GENE TARGETING; GLUCOSE HOMEOSTASIS; HORMONE ACTION; HYPOINSULINEMIA; INSULIN RESISTANCE; KNOCKOUT MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PANCREAS ISLET BETA CELL; PATHOGENESIS; SIGNAL TRANSDUCTION;

EID: 0034525135     PISSN: 0334018X     EISSN: None     Source Type: Journal    
DOI: 10.1515/jpem-2000-s611     Document Type: Conference Paper

References (53)

1. The structure of insulin receptor and its subunits. Evidence for multiple nonreduced forms and a 210K possible proreceptor
2. Human insulin receptor gene. Partial sequence and amplification of exons by polymerase chain reaction
3. Direct demonstration that receptor cross-linking or aggregation is important in insulin action
4. Human insulin receptors mutated at the ATP-binding site lack protein tyrosine kinase activity and fail to mediate postreceptor effects of insulin
5. Replacement of lysine residue 1030 in the putative ATP-binding region of the insulin receptor abolishes insulin- and antibody-stimulated glucose uptake and receptor kinase activity
6. Insulin stimulates serine and tyrosine phosphorylation in the juxtamembrane region of the insulin receptor
7. Crystal structure of the activated insulin receptor tyrosine kinase in complex with peptide substrate and ATP analog
8. Mutations in the insulin receptor gene
9. Syndromes of insulin resistance. From patient to gene and back again
10. Role of IRS-2 in insulin and cytokine signalling
11. Characterization of insulin receptor substrate 4 in human embryonic kidney 293 cells
12. Cloning, tissue expression, and chromosomal localization of the mouse IRS-3 gene
13. A Grb2-associated docking protein in EGF- and insulin-receptor signalling
14. Tyrosine phosphorylation of paxillin and focal adhesion kinase during insulin-like growth factor-1-stimulated lemellipodial advance
15. A putative modular domain present in diverse signaling proteins
16. Structure of the IRS-1 PTB domain bound to the juxtamembrane region of the insulin receptor
17. Pleiotropic insulin signals are engaged by multisite phosphorylation of IRS-1
18. Insulin-induced phosphorylation of the 46- and 52-kDa Shc proteins
19. Protein modules and signalling networks
20. Cloning of PI3 kinase-associated p85 utilizing a novel method for expression/cloning of target proteins for receptor tyrosine kinases
21. Type I phosphatidylinositol kinase makes a novel inositol phospholipid, phosphatidylinositol-3-phosphate
22. Does mitogen-activated-protein kinase have a role in insulin action? The cases for and against
23. The proto-oncogene product c-Crk associates with insulin receptor substrate-I and 4PS. Modulation by insulin growth factor-I (IGF) and enhanced IGF-I signalling
24. Association of insulin receptor substrate 1 with simian virus 40 large T antigen
25. 2+- ATPases in muscle and heart
26. 14-3-3 Protein binds to insulin receptor substrate-1, one of the binding sites of which is in the phosphotyrosine binding domain
27. Altering the genome by homologous recombination
28. Altering mice by homologous recombination using embryonic stem cells
29. Alternative pathway of insulin signalling in mice with targeted disruption of the IRS-1 gene
30. Insulin resistance and growth retardation in mice lacking insulin receptor substrate-1
31. Early neonatal death in mice homozygous for a null allele of the insulin receptor gene
32. Targeted disruption of the insulin receptor gene in the mouse results in neonatal lethality
33. Phenotypic alterations in insulin-deficient mutant mice
34. Disruption of IRS-2 causes type 2 diabetes in mice
35. Insulin receptor substrate 3 is not essential for growth or glucose homeostasis
36. Cardiac and adipose tissue abnormalities but not diabetes in mice deficient in GLUT4
37. Development of a novel polygenic model of NIDDM in mice heterozygous for IR and IRS-I null alleles
38. Insulin administration alters gonadal steroid metabolism independent of changes in gonadotropin secretion in insulin resistant women with the polycystic ovary syndrome (PCO)
39. Insulin-mediated skeletal muscle vasodilation contributes to both insulin sensitivity and responsiveness in lean humans
40. Receptor mediated transport of insulin across endothelial cells
41. Transendothelial insulin transport is not saturable in vivo. No evidence for a receptor-mediated process
42. Deletion of a DNA polymerase beta gene segment in T cells using cell type-specific gene targeting
43. A muscle-specific insulin receptor knockout exhibits features of the metabolic syndrome of NIDDM without altering glucose tolerance
44. Non-insulin-dependent diabetes mellitus, abnormal lipoprotein metabolism and atherosclerosis
45. Redistribution of substrates to adipose tissue in mice with selective insulin resistance in muscle promotes obesity
46. Dual roles for glucokinase in glucose homeostasis as determined by liver and pancreatic beta cell-specific gene knock-outs using Cre recombinase
47. Loss of insulin signaling in hepatocytes leads to severe insulin resistance and progressive hepatic dysfunction
48. Banting Lecture 1990. Beta-cells in type II diabetes mellitus
49. Lilly Lecture 1994: The beta-cell in diabetes: From molecular genetics to clinical research
50. Feedback inhibition of insulin secretion by insulin: Relation to the hyperinsulinemia of obesity
51. Exocytosis of insulin promotes insulin gene transcription via the insulin receptor/PI-3 kinase/p70 s6 kinase and CaM kinase pathways
52. Inducible gene targeting in mice
53. Tissue-specific knockout of the insulin receptor in pancreatic β cells creates an insulin secretory defect similar to that in type 2 diabetes